Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 4
1966 6
1967 8
1968 12
1969 3
1970 12
1971 21
1972 12
1973 18
1974 17
1975 40
1976 38
1977 68
1978 67
1979 48
1980 43
1981 64
1982 67
1983 49
1984 51
1985 54
1986 59
1987 80
1988 101
1989 106
1990 140
1991 145
1992 175
1993 202
1994 195
1995 218
1996 195
1997 188
1998 197
1999 209
2000 223
2001 222
2002 246
2003 274
2004 283
2005 305
2006 270
2007 307
2008 329
2009 343
2010 383
2011 414
2012 430
2013 398
2014 380
2015 360
2016 311
2017 282
2018 310
2019 368
2020 385
2021 330
2022 187
2023 130
2024 113

Search Results

9,710 results

Results by year

Filters applied: . Clear all
Page 1
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, Falk S, Gillmore R, Wadsley J, Patel K, Anthoney A, Maraveyas A, Iveson T, Waters JS, Hobbs C, Barber S, Ryder WD, Ramage J, Davies LM, Bridgewater JA, Valle JW; Advanced Biliary Cancer Working Group. Lamarca A, et al. Lancet Oncol. 2021 May;22(5):690-701. doi: 10.1016/S1470-2045(21)00027-9. Epub 2021 Mar 30. Lancet Oncol. 2021. PMID: 33798493 Free PMC article. Clinical Trial.
NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Nichetti F, Rota S, Ambrosini P, Pircher C, Gusmaroli E, Droz Dit Busset M, Pusceddu S, Sposito C, Coppa J, Morano F, Pietrantonio F, Di Bartolomeo M, Mariani L, Mazzaferro V, de Braud F, Niger M. Nichetti F, et al. JAMA Netw Open. 2024 Jan 2;7(1):e2350756. doi: 10.1001/jamanetworkopen.2023.50756. JAMA Netw Open. 2024. PMID: 38190183 Free PMC article.
Leucovorin rescue revisited.
Bertino JR. Bertino JR. J Clin Oncol. 1990 Feb;8(2):193-5. doi: 10.1200/JCO.1990.8.2.193. J Clin Oncol. 1990. PMID: 2299365 No abstract available.
[FOLFOX].
Mishima H, Ikenaga M, Tsujinaka T, Yasui M, Kashiwazaki M, Miyazaki M, Hirao M, Fujitani K, Nakamori S. Mishima H, et al. Gan To Kagaku Ryoho. 2006 Jul;33(7):911-4. Gan To Kagaku Ryoho. 2006. PMID: 16835479 Japanese.
[Methotrexate].
Harten P. Harten P. Dtsch Med Wochenschr. 2001 May 18;126(20):610. doi: 10.1055/s-2001-14101-1. Dtsch Med Wochenschr. 2001. PMID: 11402932 German. No abstract available.
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
Boige V, Blons H, François E, Ben Abdelghani M, Phelip JM, Le Brun-Ly V, Mineur L, Galais MP, Villing AL, Hautefeuille V, Miglianico L, De La Fouchardière C, Genet D, Levasseur N, Levaché CB, Penel N, Mitry E, Jacquot S, Aparicio T, Brument E, Gourgou S, Castan F, Bouché O. Boige V, et al. JAMA Netw Open. 2023 Sep 5;6(9):e2333533. doi: 10.1001/jamanetworkopen.2023.33533. JAMA Netw Open. 2023. PMID: 37721754 Free PMC article. Clinical Trial.
9,710 results